Literature DB >> 16964248

FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.

Armando van der Horst1, Alida M M de Vries-Smits, Arjan B Brenkman, Miranda H van Triest, Niels van den Broek, Frédéric Colland, Madelon M Maurice, Boudewijn M T Burgering.   

Abstract

FOXO (Forkhead box O) transcription factors are important regulators of cellular metabolism, cell-cycle progression and cell death. FOXO activity is regulated by multiple post-translational modifications, including phosphorylation, acetylation and polyubiquitination. Here, we show that FOXO becomes monoubiquitinated in response to increased cellular oxidative stress, resulting in its re-localization to the nucleus and an increase in its transcriptional activity. Deubiquitination of FOXO requires the deubiquitinating enzyme USP7/HAUSP (herpesvirus-associated ubiquitin-specific protease), which interacts with and deubiquitinates FOXO in response to oxidative stress. Oxidative stress-induced ubiquitination and deubiquitination by USP7 do not influence FOXO protein half-life. However, USP7 does negatively regulate FOXO transcriptional activity towards endogenous promoters. Our results demonstrate a novel mechanism of FOXO regulation and indicate that USP7 has an important role in regulating FOXO-mediated stress responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964248     DOI: 10.1038/ncb1469

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  216 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

3.  Enzymatic assays for assessing histone deubiquitylation activity.

Authors:  Robyn T Sussman; Xiao-Yong Zhang; Steven B McMahon
Journal:  Methods       Date:  2011-04-12       Impact factor: 3.608

Review 4.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

5.  Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation.

Authors:  Karin Hochrainer; Gianfranco Racchumi; Sheng Zhang; Costantino Iadecola; Josef Anrather
Journal:  Cell Mol Life Sci       Date:  2012-01-20       Impact factor: 9.261

Review 6.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 7.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

8.  XIAP monoubiquitylates Groucho/TLE to promote canonical Wnt signaling.

Authors:  Alison J Hanson; Heather A Wallace; Tanner J Freeman; R Daniel Beauchamp; Laura A Lee; Ethan Lee
Journal:  Mol Cell       Date:  2012-02-01       Impact factor: 17.970

9.  Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors.

Authors:  Colin R O'Dowd; Matthew D Helm; J S Shane Rountree; Jakub T Flasz; Elias Arkoudis; Hugues Miel; Peter R Hewitt; Linda Jordan; Oliver Barker; Caroline Hughes; Ewelina Rozycka; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Stephanie Feutren-Burton; Scarlett Dvorkin; Gerald Gavory; Timothy Harrison
Journal:  ACS Med Chem Lett       Date:  2018-02-21       Impact factor: 4.345

Review 10.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.